Emerging Developments in Gene Therapy and DNA Vaccines (Technical Insights)

Emerging Developments in Gene Therapy and DNA Vaccines (Technical Insights)

 

RELEASE DATE
28-May-2003
REGION
Global
Research Code: D260-01-00-00-00
SKU: HC01301-GL-TR_05590
AvailableYesPDF Download

$3,950.00

Special Price $2,962.50 save 25 %

In stock
SKU
HC01301-GL-TR_05590

$3,950.00

$2,962.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This report covers developments in gene therapy and DNA vaccines, including new technologies; novel applications; market analysis; and key developments

Table of Contents

Overview and Perspective

  • Overview
  • The Technologies
  • Scope and Methodology

The Marketplace

  • Market Analysis
  • Barriers to Commercialization

The History of Gene Therapy

Types of Technologies

  • The Beginning
  • The Setbacks
  • The Middle Ground

Alternatives to Gene Transfection

  • Retroviruses
  • Adenoviruses
  • Adeno-Associated Virus
  • Naked DNA
  • Chemical and Physical Methods
  • Other Types of Technologies

Gene Therapy Market

Market Sectors that Will Be Affected by Gene Therapy

Barriers to Commercialization

Vector and Gene-Transfer Technologies

Gene Therapies for Specific Disorders

Antisense Therapies

Aptamer Therapies

DNA Vaccines

Electroporation

  • Mirus: Transport Genes to Intracellular Targets
  • Genteric Inc: Gene Pills
  • CytRx and Merck: Transfection Technology Brings Milestone Payment
  • Purdue: RNA-ATP Motors As Gene Delivery Vehicles?
  • Athersys: Synthetic Microchromosomes
  • Targeted Genetics: Large Genes Packaged in Adeno-Associated Virus
  • Targeted Genetics: Synthetic Liposome Gene Delivery Slows Tumor Growth
  • Valentis and Schering AG: Polymer Based Synthetic Gene Delivery
  • University of South Carolina: Silica and Polystyrene Nanotubes for Gene Delivery?
  • Washington University: Nano Polish Dumplings Carry DNA
  • Rice University: Unraveling the Mystery of Membrane Fusion
  • Stanford University: Integrase Makes Gene Therapy Safer
  • University of California; Santa Barbara: Hydrogel Scaffolds for Gene Delivery
  • Introgen: Adenoviral Vectors For Cancer Therapy
  • Glygen: Glycoconjugates for Gene Therapy

Gene- and RNA-Regulation Therapies

  • GenVec: TNF Gene Therapy Shrinks Tumors
  • Ceregene: Growth Factor Genes for Neurologic Disorders
  • Targeted Genetics: CF Gene Therapy
  • Introgen: PTEN Gene Therapy For Restenosis And Melanoma
  • Dynavax: Immunostimulatory DNA Sequences in Asthma Trials
  • Hybridon: Tiny Pieces of DNA May Fight Infections; Cancers; and Inflammation
  • Angiogenic Therapies: Blocking or Promoting Blood Vessel Growth

Genetically Engineered Cell Therapies

  • Hybridon: Antisense Compound for Prostate Cancer
  • Isis: Antisense for Crohn’s disease in Phase III
  • Isis: Antisense for Pancreatic Cancer in Phase II
  • Isis: Antisense Inhibitor of TNF-alpha in Phase II for Arthritis
  • Isis/Lilly: Antisense Drug for Non-Small Cell Lung Cancer Disappoints
  • Isis Regains Hepatitis Compound from Elan
  • Genta: Antisense Drug for Colorectal Cancer Enters Clinical Trials
  • AVI: Oral Antisense Agents
  • AVI: Antisense Drug Protects Kidneys
  • AVI: Antisense Drug Boosts Cancer Chemotherapy
  • AVI: Antisense Vs. Restenosis
  • AVI: Antisense Compound Prolongs Drug Half-Life
  • AVI: Antisense Drug Prolongs Paclitaxel Life
  • Acorda: Antisense Technology for Spinal Repair
  • NovaRx: Antisense Cell Vaccine in Phase II Trial for Cancer
  • EpiGenesis Pharmaceuticals: Antisense Targets Asthma Receptor

Gene Repair Technologies

  • Duke University: Aptamers For The Rational Design Of Drug-Antidote Pairs
  • Eyetech Pharmaceuticals: Anti-VEGF Aptamer Blocks Blood Vessel Growth
  • Cyntellect and University of Texas: Thioaptamers Resist Bioterrorism
  • Vitex: Aptamers To Remove Prions from Blood Products
  • Genta Inc: Decoy Aptamers for Cancer
Related Research
This report covers developments in gene therapy and DNA vaccines, including new technologies; novel applications; market analysis; and key developments
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number D260-01-00-00-00
Is Prebook No